Summary
- Current Price
- As of today, ANTX price is $5.93, down -2.47% on
- Current Price All-Time High
- ANTX price is currently -74.85% below its historical high of $23.58 set on
- Market Cap
- ANTX current market cap is $214M, up +622.35% over the past 365 days
- Revenue
- ANTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ANTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | AN2 Therapeutics, Inc. |
| Ticker | NASDAQ: ANTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | an2therapeutics.com |
| Employees | 22 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $5.93 | ||
| Price, 1D Change | -2.47% | |
| $214M | ||
| - | ||
| - | ||
| 0.58 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.16 | ||
| EPS, 1Y Change | +32.34% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | ANMTU | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.16 | ||
| EPS Estimate | -$1.05 | N/A |
| EPS Est. Change | +10.23% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $5.93 | ||
| Price Target | $9.00 | - |
| Price Tgt. Change | +51.77% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.63 | -$1.72 | -5.56% | |
| -$1.12 | -$1.16 | -3.94% | |
| -$1.05 | N/A | +10.23% | |
| -$0.93 | N/A | +20.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +449.07% | ||
| -26.88% | ||
| +622.35% | ||
| +20.09% | ||
| 0.00% | ||
| 0.00% | ||
| +32.34% | ||
| +47.20% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $5.93 | ||
| $2.92 | ||
| $4.79 | ||
| $3.45 | ||
| $4.87 | ||
| $0.33 | ||
| 0.58 | ||
| $0.40 | ||
| 68.49 | ||
| 65.67% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.16 | ||
| $0.00 | ||
| - | ||
| -$38.11M | ||
| - | ||
| -$35.17M | ||
| - | ||
| -$38.11M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 6.87 | ||
| 6.87 | ||
| - | ||
| - | ||
| 7.93 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.61 | ||
| -3.46 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $53.06M | ||
| $58.00M | ||
| $61.95M | ||
| $59.94M | ||
| $8.89M | ||
| $8.72M | ||
| $0.00 | ||
| $0.00 | ||
| $3.02M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $35.17M | ||
| $38.11M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$29.83M | ||
| $28.31M | ||
| $113.00K | ||
| $0.00 | ||
| -$29.83M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Guggenheim | ||
| Leerink Partners | → | |
| JMP Securities | → | |
| Citizens Capital Markets | → | |
| Citizens Capital Markets | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| TD Cowen | → | |
| JMP Securities | → | |
| Leerink Partners | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ANTX
FAQ
- What is the ticker symbol for AN2 Therapeutics, Inc.?
- The ticker symbol for AN2 Therapeutics, Inc. is NASDAQ:ANTX
- Does AN2 Therapeutics, Inc. pay dividends?
- No, AN2 Therapeutics, Inc. does not pay dividends
- What sector is AN2 Therapeutics, Inc. in?
- AN2 Therapeutics, Inc. is in the Healthcare sector
- What industry is AN2 Therapeutics, Inc. in?
- AN2 Therapeutics, Inc. is in the Biotechnology industry
- What country is AN2 Therapeutics, Inc. based in?
- AN2 Therapeutics, Inc. is headquartered in United States
- When did AN2 Therapeutics, Inc. go public?
- AN2 Therapeutics, Inc. initial public offering (IPO) was on March 25, 2022
- Is AN2 Therapeutics, Inc. in the S&P 500?
- No, AN2 Therapeutics, Inc. is not included in the S&P 500 index
- Is AN2 Therapeutics, Inc. in the NASDAQ 100?
- No, AN2 Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is AN2 Therapeutics, Inc. in the Dow Jones?
- No, AN2 Therapeutics, Inc. is not included in the Dow Jones index
- When was AN2 Therapeutics, Inc. last earnings report?
- AN2 Therapeutics, Inc.'s most recent earnings report was on August 14, 2025
- When does AN2 Therapeutics, Inc. report earnings?
- The date for AN2 Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ANTX Official Website www.an2therapeutics.com
- ANTX Profile on Yahoo Finance finance.yahoo.com/quote/ANTX
- ANTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/antx